Table 4.
Hydrogel | Active Ingredient | Type of Disease | In Vitro Cell Line | In Vivo Model | Conclusion | Reference |
---|---|---|---|---|---|---|
Thermosensitive chitosan-based | Disulfiram(DSF) | Cancer | Human HCC cell lines (SMMC-7721 cells) | - | A novel injectable sustained formulation for anticancer drugs aimed at the delivery of DSF for long-term cancer treatment | [61] |
Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid) | Doxorubicin | Breast cancer | MCF-7 cells | - | Cytocompatible and exert no/negligible cytotoxicity on MCF-7 cells and has the potential for local therapy of breast cancer | [62] |
pH-sensitive poly(lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) triblock copolymers | Herceptin | Breast cancer | - | SK-BR-3 tumor bearing mice | Great potential for preventing the relapse of HER2+ breast tumors after breast-conserving surgery with ↑ therapeutic efficacy, ↓ side effects and ↑ patient compliance | [63] |
pH-sensitive injectable-polysaccharide-based self-healing hydrogels | Doxorubicin | Hepatocellular carcinoma | HepG2(release of drug from hydrogel) L929 cells (Cytotoxicity test of the hydrogel) |
- | Self-healing property with high drug-loading ratio could prolong their lifetime during implantation and provide the benefit of nominally invasive surgery | [64] |
Dual pH- and temperature-responsive physically crosslinked injectable hydrogel | Cancer | Oncolytic adenoviruses | - | Human xenograft tumor models | Exhibited ↑ and long-term antitumor therapeutic effects in tumor models and might have potential for long-term cancer treatment | [65] |
Novel palladium nanosheet (Pd NS)-based chemo-photothermalhydrogel (Pd Gel) | Palladium and doxorubicin | Cancer | - | Mouse | A novel anticancer strategy that allows the release of doxorubicin more precisely, eliminate tumor more efficiently and inhibit tumor metastasis more persistently | [66] |
ABA triblock copolymers of vitamin D-functionalized polycarbonate and poly(ethylene glycol), that is, VDm-PEG-VDm were synthesized and employed to form physically crosslinked injectable hydrogels | Bevacizumab; Avastin | Cancer | HCT116 xenograft mouse models | Injection of the hydrogel was effective to show antimetastatic activity as that of 4× weekly injections of Avastin thus ↓ the injection frequency and may ↑ patient compliance to treat metastatic cancer | [67] | |
pH-responsive injectable hydrogels made of a supramolecular cross-link network | doxorubicin | Cancer | L929 mouse fibroblasts | - | Showed biocompatibility, controlled release profiles and tunable properties which show a ↑ potential as a drug-releasing material for localized treatments | [68] |
Triblock Copolymers of Vitamin E-Functionalized Polycarbonate and Poly(ethylene glycol) | Herceptin | Breast cancer | Human breast cancer cell lines (antitumor specificity and efficacy) | BT474 tumor-bearing mice- (biocompatibility and biodegradability) | ↑ potential for use in subcutaneous and sustained delivery of antibodies to ↑ therapeutic efficacy and/or ↑ patient compliance as compared to intravenous and subcutaneous delivery of Herceptin in solution form | [69] |
pH-responsive injectable hydrogels with mucosal adhesiveness based on chitosan-grafted-dihydrocaffeic acid and oxidized pullulan | Doxorubicin | Colon tumor | Colon tumor cells (HCT116 cells) | - | Showed good drug release, effectively killing colon tumor cells, ideal candidates for development of colon cancer drug delivery carriers /mucoadhesive drug delivery systems | [70] |
Alginate hydrogel system | Angiogenesis with vascular endothelial growth factor (VEGF) | Cardiovascular diseases | Human microvascular dermal endothelial cells | Act as a new generation of therapeutic delivery vehicle by combining long-term in vivo therapeutic advantages with minimal invasion to treat cardiovascular diseases | [71] | |
Dual-responsive (pH and ROS) injectable hydrogels encapsulating drug-loaded micelles | Amikacin, andNaproxen | Wound healing | SD male rats | Possess good biocompatibility with efficient antibacterial and anti-inflammatory action, ↑ the healing process and promising to be applied topically against various microbial infections | [72] | |
Alginate–chitosan hydrogels | IgG model antibodies and Fab antibody fragments | Applications in drug delivery and regenerative medicine | - | - | Offers controlled delivery of antibodies and antibody fragments and will be promising formulation for several applications in drug delivery and regenerative medicine | [73] |
Dopamine-based and polydopamine crosslinked injectable hydrogels | Dopamine and metronidazole | Parkinson’s disease | - | mouse L929 fibroblast cells | Can be used as long-term, localized, sustained release injectable system for dopamine as well as anti-inflammatory drugs to treat Parkinson | [74] |
Covalently crosslinked composite hydrogel embedded with microspheres | Soft tissue engineering | - | - | Can be exploited as a potential opportunity to use this injectable composite gel scaffold in protein delivery and soft tissue engineering applications | [75] | |
Gelatin-hydroxyphenyl propionic acid (Gtn-HPA) and hyaluronic acid-tyramine (HA-Tyr)-based hydrogels | Human epidermal growth factor (hEGF) | Ophthalmic applications | Hydrodynamic model, giving a normalized diffusion and release of hEGF and provide the most suitable explanation for the measured solute diffusion coefficient | [76] | ||
Porous alginate gels | Peptide antigen | Immunotherapies | - | Nonobese diabetic mouse model of type 1 diabetes | A noninflammatory biomaterial system can generate antigen-specific, that may enable the development of new therapies to treat transplant rejection/autoimmune diseases | [77] |
Self-healing injectable micelle/hydrogel composites quaternized chitosan (QCS) solution and benzaldehyde-terminated poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) (PEO99-b-PPO65-b-PEO99, Pluronic® F127 (PF127)) (PF127-CHO) solution | Curcumin | Wound dressing for joints skin wound healing | Female Kunming mice | Self-healing antibacterial adhesive hydrogels with good mechanical property offer significant promise as dressing materials for joints skin wound healing | [78] | |
Alginate-gelatin injectable hydrogel | Oligochitosan coated cerium oxide nanoparticles | Age-related macular degeneration | Human retinal pigment epithlium-19 (ARPE-19) and umbilical endothelium | - | Biocompatible and have ↑ potential in protecting cells from angiogenesis, apoptosis, and production of proinflammatory cytokines with controlled drug release | [79] |
Decellularized injectable cardiac and skeletal muscle extracellular matrix hydrogel | - | Potential scaffolds for tissue regeneration and/or repair for treating myocardial infarction, heart failure and peripheral artery disease | - | - | Tissue specific biomaterial therapies with minimal invasion | [80] |
Polysaccharide-based hydrogels(N-carboxyethyl chitosan and oxidized sodium alginate) | Neural stem cells delivery | Neurological disorders | Neural stem cells | - | Neural stem cells transplantation and management of neurological diseases | [81] |
Non-degradable dendritic polyglycerol sulfate (dPGS) hydrogel | Dendritic polyglycerol sulfate | Osteoarthritis | - | - | Formulation having good viscoelastic properties and has the benefit of being much less easily displaced from its injection site | [82] |
Conductive anti-oxidant hydrogels (N-carboxyethyl chitosan and oxidized hyaluronic acid-graft-aniline tetramer | Amoxicillin | Wound dressing | C2C12 myoblast cells (Cytocompatibility) Escherichia coli and Staphylococcus aureus (Antibacterial activity) |
Male Kunming mice | Have good antibacterial, biodegradation, electroactive and free radical scavenging property to efficiently prevent the wound infection and can be designed as an electroactive injectable hydrogel with promising applications | [83] |
Injectable poly(ethylene glycol) (PEG)–gelatin hydrogel | Murine adipose-derived stem cells | Wound Healing and tissue regeneration | - | Murine wound healing model | Significantly ↑ cell retention, ↑ angiogenesis, and ↑ wound closure and can be used for regulating stem cell behaviors in 3D culture, delivering cells for wound healing and other tissue regeneration applications | [84] |
Polyplex Micelle-Loaded Injectable Hydrogels | MicroRNA-29 | Intervertebral disc degeneration(IDD) | Rabbits (therapeutic efficacy on fibrosis Inhibition) Sprague-Dawley rats (In vivo delivery analysis) |
Successfully stop the expression of matrix metalloproteinases, prevent the fibrosis process and reverse IDD in animal models | [85] | |
Collagen–chitosan-based hydrogel | Thymosin β4, (a 43-amino acid peptide) | Myocardial Infarction | Monolayers of BHK-21 | Stimulate angiogenesis and epicardial heart cell migration can be considered as a carrier of other negatively charged active biomolecules and thus shows numerous applications | [86] | |
Chitosan hydrogel | Human placenta-derived mesenchymal stem cell -derived exosomes | Hindlimb Ischemia | - | Murine model | Can ↑ the retention and stability of exosomes and further ↑ the therapeutic effects that may facilitate the development of easy and effective approaches for assessing and enhancing the therapeutic effects of stem cell-derived exosomes | [87] |
Sustained release, thermosensitive polymeric [poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic acid-co-glycolic acid) (PLGA-PEG-PLGA)]hydrogel | Avastin® | Posterior segment disorders | - | Rat | A promising candidate for ocular drug delivery of Avastin® through intravitreal injection | [88] |
Catheter-injectable hydrogel utilizing a polymer–nanoparticle crosslinking mechanism | - | Various therapeutic applications | Wistar rats | Biocompatible, cell-signaling and can be differentially released with distinct elution profiles, allowing precise control over drug delivery | [89] | |
Self-healing hydrogel based on chondroitin sulfate multiple aldehyde and N-succinyl-chitosan | Cells encapsulated in the hydrogel | Cell carrier and in tissue engineering | Rat model | Shows biodegradability, produced ↓ inflammatory response and having potential application as a cell carrier and in tissue engineering. | [90] | |
Physiological temperature-responsive controllable NO-releasing redox injectable hydrogel | Nitric oxide(NO) | Cardiovascular diseases | - | Mice | Significantly ↑ the angiogenesis and new blood vessels formation by regulating the sustained release of NO and redox equilibrium in animal model. It has a ↑ potential in preventing and treating diseases | [91] |